Try our Advanced Search for more refined results
Health - December, 2007
89 articles
- Nursing Homes No Longer Hands-Off Investments
- Plaintiffs Appeal Average Wholesale Price Ruling
- Ex-HealthSouth CFO Pleads Guilty In Bank Suit
- Paddock Labs Attorney Fee Bid Nixed
- SEC Seeks Disgorgement From Safescript VIPs
- Judge Won't Toss State Claims Against Roche
- Abbott Faces $70M Suit Over Discontinued Stent
- Health Cases To Watch In 2008
- Judge Deals Rare Class Denial In Sanofi FLSA Suit
- Are No-Sue Agreements Appropriate For My Practice?
- GSK Hit With Another Avandia Wrongful Death Suit
- Institute Fires Off Suit Against Amgen Over Royalties
- Judge Approves $3.2B Settlement In Tyco Case
- Northwestern Sells Drug Royalty Rights For $700M
- Post-Scandal, Trustee Balks At St. Vincent Fees
- AstraZeneca Blasted For Seroquel Discovery Lapses
- UnitedHealth Questions Lerach's Interest in Case
- Indirect Purchasers Bail Out Of Ditropan Suit
- Shareholders Fight Bid To Dismiss Part Of Apotex Suit
- Health Legislation To Watch In 2008
- Vitamin C Resellers Want Antitrust Suit Tossed
- Tort Costs Decrease For 1st Time This Decade: Study
- FDA To Crack Down On Drug-Coated Stents: Report
- EU Agency Probes Safety Of Pfizer's Champix
- The Shifting Scope Of Patentable Subject Matter
- Two NuvaRing Cases Remanded To State Court
- Lilly Wins Stay In Zyprexa Whistleblower Suit
- Barr Sues To Block Generic Seasonale
- Merck Recalls 1.2M Vaccine Doses
- Device Co. Closes Up Suture Suit Against Abbott
- HealthSouth, Drs. To Pay $14.9M In Kickbacks Case
- CMS: Draconian Rulemaking For Physicians, Testing
- Claim Constructions Adopted In Catheter Patent Suit
- Pfizer's Drug Distribution Deal Raises Concerns
- Merck Puts Up $10M To Fix Creek Pollution
- Depomed Secures Summary Judgment Against Ivax
- Applied Medical Clears Seagate Test In Tyco Case
- Congress Questions Results Of Cholesterol Study
- AstraZeneca Fires Off 7 Suits Over Crestor ANDAs
- Wyeth Settles With J&J Unit Over Effexor Patent
- D.C. Council Moves To Rein In Drug Industry
- Jury Hands Bard $185M Verdict In Graft Patent Case
- Director Bonuses And The Entire Fairness Test
- Biovail Settles Securities Suit For $138M
- Invitrogen, Genetic Applications Settle Patent Fight
- Merck To Develop New Drugs Despite Litigation Risks
- Pfizer Pushes To Toss More Cases From Bextra MDL
- Injunction Lifted In Metabolite Case Against LabCorp
- Novo Nordisk Settles Patent Dispute With Pfizer
- Judge Nails Medtronic With $226M Screw Judgment
- Pfizer Moves To Block Four Experts In Viagra MDL
- AstraZeneca Appeals $12.9M Judgment In AWP Case
- Free Drug Samples May Limit Costs In Antitrust Suits
- Unintentional Privacy Breaches Can Incur Damages
- Nexium, Prilosec Do Not Increase Heart Risks: FDA
- Class Certified In Medtronic Defibrillator Case
- Research Firm To Pay For Seroquel Discovery Request
- Pfizer Sues Cobalt Over Lipitor Patent
- Deloitte & Touche Fined $1M For Drug Co. Audit
- Labor Dept. Finds CVS Violated Child Labor Laws
- RTI Opposes Split Of Becton Antitrust, Patent Claims
- ImClone Settles Patent Row With Yeda, Sanofi
- Judge Stands By Ruling For Wyeth In Prempro Case
- Aredia Plaintiffs Slam Novartis Bid For Ex-Parte Talks
- Medtronic-Cordis Coronary Stent Suit Heads To Trial
- Pfizer FLSA Suit On Hold For Parallel MSJ Ruling
- Abbott Labs Sues Zydus Over Depakote
- AstraZeneca Handed Partial Win In Seroquel Fight
- Novartis, Sun, Watson Strike Deal In Exelon MDL
- Ex-UnitedHealth CEO To Pay $800M In Settlements
- Cyberonics Settles Shareholder Suits Over Backdating
- Nigeria Cuts Off Talks With Pfizer In Drug Trial Case
- Judge Blasts Milberg, Skadden In Settlement Denial
- Duane Morris Adds Four IP Attorneys
- Novartis' Anti-Seizure Drug New Target Of PL Suit
- Judge Denies Fee Award To Pfizer In Celebrex Case
- Appeals Court Orders UnitedHealth To Turn Over Docs
- Biovail Settles Cardizem Suit With Watson Unit
- Merck Reveals $670M Payment To Settle Probes
- Imaging Antitrust Suit Against Hospital Survives
- Red Cross Wants J&J Expert's Testimony Tossed
- Trial Date Set In Bextra, Celebrex Case
- Tug-Of-War Over Fosamax Class Continues
- Growth Of Specialty Pharma Draws Generics Litigation
- King Pharmaceuticals Loses Rehearing Bid
- Judge OKs Personal Injury Claims Against St. Vincent
- Judge Finds Warner-Lambert Accupril Patent Enabled
- Judge Extends Options Freeze For UnitedHealth CEO
- Court Won't Stay Generic Approval Of HDI Body Oil